BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
8/25/2014 2:47:00 PM | Browse: 361 | Download: 369
Publication Name World Journal of Gastroenterology
Manuscript ID 8929
Country of Manuscript Source Hungary
Received
2014-01-13 11:17
Peer-Review Started
2014-01-23 09:47
To Make the First Decision
2014-02-14 13:51
Return for Revision
2014-02-20 10:24
Revised
2014-03-12 02:32
Second Decision
2014-04-23 09:28
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief
2014-04-23 10:22
Articles in Press
2014-05-23 10:23
Publication Fee Transferred
Edit the Manuscript by Language Editor
2014-06-30 08:55
Typeset the Manuscript
2014-07-16 09:48
Publish the Manuscript Online
2014-08-07 10:34
ISSN 1007-9327 (print) and 2219-2840 (online)
Open Access
Copyright
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Gastroenterology and Hepatology
Manuscript Type Randomized Controlled Trial
Article Title Is rectal indomethacin effective in preventing of post-endoscopic retrograde cholangiopancreatography pancreatitis?
Manuscript Source Unsolicited Manuscript
All Author List Zoltán Döbrönte, Zoltán Szepes, Ferenc Izbéki, Judit Gervain, László Lakatos, Gyula Pécsi, Miklós Ihász, Lilla Lakner, Erzsébet Toldy and László Czakó
Funding Agency and Grant Number
Funding Agency Grant Number
TÁMOP-4.2.2.A-11/1/KONV 2012-0035
OTKA K101521
Corresponding author László Czakó, MD, PhD, 1st Department of Medicine, University of Szeged, Dugonics tér, P.O.Box: 427, 6701 Szeged, Hungary. czako.laszlo@med.u-szeged.hu
Keywords Endoscopic retrograde cholangiopancreatography; Post-endoscopic retrograde cholangiopancreatography pancreatitis; Hyperamylasaemia; Non-steroidal anti-inflammatory drugs; Indomethacin
Core Tip Acute pancreatitis is the most common and potentially fatal complication of endoscopic retrograde cholangiopancreatography (ERCP). Non-steroidal anti-inflammatory drugs have been suggested to be effective in prospective controlled trials, but the results are inconclusive. A prospective, randomised, placebo-controlled multicentre study was therefore conducted in five endoscopic units. The results for 665 patients who randomly received a suppository containing 100 mg indomethacin or placebo before ERCP were evaluated. There was no difference between the indomethacin and placebo groups in the incidence of either post-ERCP pancreatitis or hyperamylasaemia. Rectal indomethacin is not effective in preventing post-ERCP pancreatitis in average-risk patients.
Publish Date 2014-08-07 10:34
Citation Döbrönte Z, Szepes Z, Izbéki F, Gervain J, Lakatos L, Pécsi G, Ihász M, Lakner L, Toldy E, Czakó L. Is rectal indomethacin effective in preventing of post-endoscopic retrograde cholangiopancreatography pancreatitis? World J Gastroenterol 2014; 20(29): 10151-10157
Url http://www.wjgnet.com/1007-9327/full/v20/i29/10151.htm
DOI http://dx.doi.org/10.3748/wjg.v20.i29.10151
Full Article (PDF) WJG-20-10151.pdf
Full Article (Word) WJG-20-10151.doc
Manuscript File 8929-Review.docx
Answering Reviewers 8929-Answering reviewers.pdf
Biostatistics Review Certificate Biostatistician_Review_Report_20140112061356.pdf
Copyright License Agreement 8929-Copyright assignment.pdf
Institutional Review Board Approval Form or Document Ethics_Committee_20140112061615.pdf
Non-Native Speakers of English Editing Certificate 8929-Language certificate.pdf
Peer-review Report 8929-Peer reviews.pdf
Scientific Editor Work List 8929-Scientific editor work list.doc